Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Strategic Diagnostics Turns To Profit In Q4

Strategic Diagnostics (SDIX: Quote), a biotechnology-based products provider, reported fourth-quarter net income of $1.7 million or $0.08 per share, compared to a net loss of $260,000 or $0.01 per share last year.

Results for the quarter included income from discontinued operations of $3.2 million

Revenues for the quarter declined to $5.5 million from $6.3 million last year.

Click here to receive FREE breaking news email alerts for Strategic Diagnostics Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
With traders largely shrugging off the latest batch of upbeat U.S. economic data, stocks are turning in a lackluster performance in early trading on Tuesday. The major averages are showing only modest moves, lingering close to the unchanged line. Following the long, holiday weekend, stocks may move to the upside in early trading on Tuesday. The major index futures are currently pointing to a modestly higher open for the markets, with the Dow futures up by 15 points. The Swiss economy stalled in the second quarter as the improvement in household spending was insufficient to offset the weakness in exports and investment in construction. Gross domestic product remained flat from the first quarter, when it accelerated to 0.5 percent, the State Secretariat for Economic Affairs said Tuesday. Economists had expected GDP to rise 0.5 percent in the second quarter.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.